May 9, 2025
| Trial | PREMIUM |
|---|---|
| Cancer Type | Melanoma |
| Hospital(s) | Belfast City Hospital and Ulster Hospital |
| Information | PeRioperative Encorafenib + binimetinib in BRAFV600 MUtant clinically detected AJCC stage III (B/C/D) or oligometastatic stage IV Melanoma |
 |
Click Here to view Cancer Research UK trial summary |